| | | | | | | | | | | | |
| | For the Years Ended December 31, | |
| | | | | 2020 | | | 2019 | |
Cash flows from operating activities: | | | | | | | | | | | | |
| | | | | | $ | 12,115 | | | $ | 2,381 | |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | | | | | | | | | | | | |
Provision for loan losses | | | | | | | 7,550 | | | | 1,625 | |
Changes in deferred tax asset, net | | | | | | | (1,708 | ) | | | (418 | ) |
Share based compensation expense | | | | | | | 275 | | | | 231 | |
Gain on sale of SBA loans | | | | | | | (266 | ) | | | — | |
Writedown of other real estate owned | | | | | | | 10 | | | | — | |
Loss on sale of other real estate owned | | | | | | | — | | | | 38 | |
Loss on disposal of fixed assets | | | | | | | 7 | | | | — | |
Amortization of premium on securities, net | | | | | | | 60 | | | | 2 | |
Accretion of fees on derivative instruments | | | | | | | — | | | | — | |
Accretion of SBA Paycheck Protection Program fees | | | | | | | (10,223 | ) | | | — | |
Depreciation, amortization and accretion | | | | | | | 78 | | | | 869 | |
Earnings on bank-owned life insurance | | | | | | | (354 | ) | | | (258 | ) |
Changes in operating assets and liabilities: | | | | | | | | | | | | |
Originations of loans held for sale | | | | | | | (5,003 | ) | | | — | |
Proceeds from sale of loans held for sale | | | | | | | 3,840 | | | | — | |
Accrued interest receivable and other assets | | | | | | | (9,699 | ) | | | (1,324 | ) |
Accrued interest payable and other liabilities | | | | | | | (336 | ) | | | 441 | |
| | | | | | | | | | | | |
Net cash provided by (used in) operating activities | | | | | | | (3,654 | ) | | | 3,587 | |
Cash flows from investing activities: | | | | | | | | | | | | |
Net increase in interest bearing deposits in other banks | | | | | | | — | | | | (2 | ) |
(Increase) decrease in non-marketable equity securities | | | | | | | (987 | ) | | | 1,375 | |
Investment securities activity: | | | | | | | | | | | | |
| | | | | | | (1,923,756 | ) | | | (599,988 | ) |
Maturities, calls and principal paydowns | | | | | | | 1,902,560 | | | | 600,320 | |
Termination fee proceeds from derivative instruments | | | | | | | — | | | | — | |
Net originations on loans held for investment | | | | | | | (482,413 | ) | | | (120,708 | ) |
Net additions to bank premises and equipment | | | | | | | (1,354 | ) | | | (2,976 | ) |
Proceeds from disposal of fixed assets | | | | | | | 59 | | | | — | |
Construction additions on foreclosed assets | | | | | | | (230 | ) | | | (395 | ) |
Proceeds from sales of foreclosed assets | | | | | | | — | | | | 675 | |
Purchase of bank owned life insurance | | | | | | | (10,000 | ) | | | — | |
Net cash acquired from acquisition of Heritage Bancorp, Inc. | | | | | | | 16,112 | | | | — | |
| | | | | | | | | | | | |
Net cash used in investing activities | | | | | | | (500,009 | ) | | | (121,699 | ) |
Cash flows from financing activities: | | | | | | | | | | | | |
| | | | | | | 566,774 | | | | 72,559 | |
Net (repayment) proceeds from issuance of FHLB Advances | | | | | | | 40,000 | | | | — | |
Proceeds from issuance of notes payable | | | | | | | 11,000 | | | | 8,000 | |
Repayment of notes payable | | | | | | | (7,500 | ) | | | (1,500 | ) |
Proceeds from issuance of common stock - private placement offering | | | | | | | — | | | | — | |
Proceeds from issuance of common stock - initial public offering | | | | | | | — | | | | — | |
Proceeds from issuance of common stock - ESOP Contributions | | | | | | | 537 | | | | 445 | |
Proceeds from stock warrants exercised | | | | | | | — | | | | — | |
Proceeds from stock options exercised | | | | | | | 385 | | | | 301 | |
Net redemption of treasury stock | | | | | | | (38 | ) | | | (527 | ) |
| | | | | | | | | | | | |
Net cash provided by financing activities | | | | | | | 611,158 | | | | 79,278 | |
| | | | | | | | | | | | |
Increase in cash and cash equivalents | | | | | | | 107,495 | | | | (38,834 | ) |
Cash and cash equivalents at beginning of period | | | | | | | 96,065 | | | | 134,899 | |
| | | | | | | | | | | | |
Cash and cash equivalents at end of period | | | | | | $ | 203,560 | | | $ | 96,065 | |
| | | | | | | | | | | | |